Clinical Trials Browser

Phase 4 × Recruiting × relmacabtagene autoleucel × Clear all

NCT05806580 2024-10-23

Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma

Phase 4 Recruiting

Recurrence, Lymphoma, B-Cell